Guide price only. Final cost is confirmed after assessment.
At London Cartilage Clinic, we are at the forefront of meniscus regeneration, offering state-of-the-art treatments for meniscus injuries - one of the most common injuries that result in functional impairment in the knee.
Reviewed byProfessor Paul Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertise
The meniscus helps absorb impact and stabilise the knee. When it is damaged, everyday movement, exercise, and sport can become painful or unreliable.
Our focus is to preserve meniscal tissue where possible and improve the biological environment for healing, helping you stay active for longer.
Common symptoms include pain, swelling, clicking, and loss of confidence in the knee. We combine clinical assessment with MRI to define tear pattern, tissue quality, and joint alignment before recommending treatment.
Your pathway is personalised and may combine rehabilitation, targeted injection therapy, or surgery depending on symptoms, goals, and scan findings.
With specialist meniscus expertise, we focus on durable symptom relief and safer return to daily activity and sport.
Meniscus regeneration involves using regenerative medicine techniques to heal and reconstruct damaged meniscal tissue.
Treatments include MFAT, BMAC, and PRP therapy, among others.
Diagnosis typically combines specialist clinical examination with MRI. X-rays can help assess bone and joint alignment but do not directly diagnose meniscus tears; arthroscopy may be used in selected cases.
Yes, including medications, physiotherapy, and lifestyle changes.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
Patients treated with ChondroFiller show mean IKDC improvement of 32.4 points sustained at 36 months, with 70–85% achieving meaningful symptom relief at 3–5 years and reoperation rates of 3–8%.
ChondroFiller injection delivers a Type I collagen scaffold under ultrasound guidance to coat worn patellar cartilage and stimulate tissue regeneration; clinical evidence shows sustained IKDC functional improvements of approximately 30 points over three years.
ChondroFiller injection suits adults with full-thickness articular cartilage damage, recruiting host cells through an injectable collagen scaffold to deliver 70–85% meaningful symptom relief by five years and 3–8% reoperation rates.
